FDA Safety Updates Fail Antifungal Patients, Public Citizen Argues
This article was originally published in The Pink Sheet Daily
Executive Summary
Citizen petition demands removal of oral ketoconazole from the market; says FDA’s own scientists have said risks outweigh benefits and prescribing remains unacceptably high despite label changes.